UF Health Launches NIH-Sponsored Trial to ‘POuND OUT’ Painful Kidney Stones
Kidney stones can be excruciatingly painful and dangerous, but relief may be on the way. A new University of Florida Health clinical trial will test two existing drugs that may slow the growth of these stones or prevent them from forming.
World-Renowned UF Health Biochemistry Researcher Mavis Agbandje-McKenna, Ph.D., Dies
University of Florida Health biochemistry professor Mavis Agbandje-McKenna, Ph.D., whose world-renowned work on the detailed structure of viruses led to advances in gene therapy treatments for different diseases, died Wednesday (March 3) at her home near Gainesville of the neurodegenerative disease amyotrophic lateral sclerosis.
Parent Project Muscular Dystrophy Awards $348,891 Grant to University of Florida Wellstone Center
Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy, awarded the University of Florida Wellstone Muscular Dystrophy Cooperative Center a grant for $348,891.
Jennifer Bizon, Ph.D., Named Chair of UF Department of Neuroscience
University of Florida neuroscientist Jennifer Bizon, Ph.D., an expert in brain aging, has been named chair of the UF College of Medicine’s department of neuroscience.
UF Health Sepsis Study Uses AI Technology, Urinary Cellular Gene Expression for Early Detection
A groundbreaking study conducted by a multidisciplinary team of researchers at the University of Florida Sepsis and Critical Illness Research Center explores how urine analysis during early onset of sepsis may help determine the likelihood of chronic kidney problems in the long term.
UF Researchers Granted $2 Million for Liver Disease Research
UF Health researchers were granted more than $2 million to screen for fatty liver disease, in what could be the largest study of its kind. The National Institute of Health grant will fund the screening of more than 1,000 patients over the next two-and-a-half years.
UF Health Researcher Helps Show Hormone Can Reverse Inflammation From Fatty Liver Disease
Pushed by the obesity epidemic, a rising number of Americans are being diagnosed with nonalcoholic fatty liver disease, a condition that can lead to liver inflammation and cirrhosis. It is now the leading cause of liver transplantation in the United States.
Lacerta Therapeutics Strengthens Its Position in the AAV Gene Therapy Space With New Leadership
UF startup and UF Innovate | Sid Martin Biotech alum Lacerta Therapeutics, a clinical-stage gene therapy company, announced new leadership. Dr. Edgar Rodriguez-Lebron, co-founder, will serve as president and chairman of the Board of Directors. Co-founders and scientific advisors, Drs. Ken Warrington and Coy Heldermon, will round out the additions to the board. The company […]
Therapeutics Company Announces Exclusive Licensing Agreements for Hearing Loss Gene Therapy Technology Developed by UF Researcher
Decibel Therapeutics, a clinical-stage biotechnology company developing novel restorative gene therapeutics to treat hearing loss and balance disorders, has announced exclusive license agreements with the University of Florida (UF) and the University of California, San Francisco (UCSF) for an adeno-associated virus (AAV) gene therapy technology designed to restore hearing to individuals with profound, congenital hearing […]
UF Health Enrolls First Patient in Clinical Trial Aimed at Creating New Treatment for COVID-19
University of Florida Health has enrolled its first patient in a clinical trial for Regeneron Pharmaceuticals’ monoclonal antibody cocktail to treat COVID-19, a therapy that might neutralize the coronavirus and prevent it from infecting cells. UF Health is one of the hundreds of medical centers internationally participating in the blinded, placebo-controlled, randomized clinical trial to […]